Weight cycling tied to greater muscle loss

Clinical takeaway: When patients lose and regain weight repeatedly, muscle may not come back with the fat. Particularly for middle-aged and older patients on weight-loss drugs, pair those efforts with resistance activity and adequate protein to better protect muscle.

GLP-1 use is moving more patients into a weight cycling rhythm of gains and losses. This makes the body composition implications of repeated swings worth watching as more patients cycle on and off weight-loss drugs.

In this study, weight cyclers shed thigh muscle, even though after four years they ended up no lighter than their steady-weight peers. The analysis defined weight cycling as the path between annual weigh-ins, not the start and end points. Everyone finished within 5% of initial baseline, so the scale looked steady even for those who swung most.

Both groups ended the four years at essentially the same weight they started, but their change in body composition differed. Weight cyclers lost about 3.7% of thigh muscle volume, compared with about 1% in non-cyclers, nearly four times the loss, after adjustment for age, sex, baseline BMI, physical activity, diet, and other factors.

Intermuscular fat rose by roughly 2.5% in both groups, with no meaningful difference between them. Fat around the knee climbed about 12% in everyone, again with no group difference. So, the cost of cycling landed with muscle loss specifically, a finding the "yo-yo diet" framing tends to miss.

The analysis drew on 1,433 adults (mean age 61, just over half women) from the Osteoarthritis Initiative, an NIH-funded cohort study of people at risk for knee osteoarthritis. The team used AI to analyze the baseline and 48-month MRI scans, measuring thigh muscle volume, fat within the muscle, and fat around the knee, essentially automated image segmentation. Only 77 participants met the cycling definition.

Muscle lost this way tends not to return on its own. In older adults it also tracks with weaker strength, slower recovery, and higher fall risk, costs that outlast any single diet. This helps reframe the GLP-1 conversation, the concern is less about any single drug than the on and off weight pattern these therapies can encourage.

"Fat loss is just one piece of a much larger puzzle that includes how weight loss affects arthritis, muscle, bone, and other factors. As more people use effective weight-loss therapies, we need to be thinking about how those pieces fit together," said Thomas Link, MD, PhD, of the University of California, San Francisco.

Source: Marth AA, et al. (2026 Jul 21) Radiology. Association of Weight Cycling with MRI-based Thigh Muscle Quality and Knee-adjacent Obesity: Osteoarthritis Initiative Data